Press release
Biopharmaceuticals and Biomedicine Market - Trends, Opportunity Analysis, 2016-2024
The biopharmaceutical and biomedicine market report covers analysis across regions – North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
Geographically, North America accounted for over 52% share of global industry revenue in 2015. However, the region is expected to lose significant market share to emerging markets of Asia Pacific and Latin America over the following decade. Healthcare expenditure in North America is highest worldwide at 16.7%. Moreover, the region is characterized by presence of robust healthcare infrastructure, presence of leading biopharmaceutical companies, and large patient pool with high spending power. In the recent past, the market in the region has witnessed sluggish growth rate. Thus, companies need to overcome structural shifts and adopt new operating model to sustain in this highly competitive market.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/18
Europe was the second-largest market for biopharmaceuticals and biomedicine, with Germany, U.K., Italy, and France being the largest revenue contributors. Europe accounted for 20.7% share of global market in 2015.
Asia Pacific is expected to be the most dynamic market, with record-setting growth rate over the forecast period (2016–2024). China and India are expected to be the largest markets in the region. Increase in FDI cap in healthcare sector in India would create lucrative growth opportunities for players seeking to strengthen their market presence in this key growth market.
Expected Commercialization of Biologics is Creating Favorable Growth Environment for Biopharmaceuticals and Biomedicine Market
Biopharmaceutical and biomedicine market growth correlates highly with per capita healthcare expenditure, healthcare amenities, and R&D spending on development of new products. Global healthcare spending rose by 1.7% Y-o-Y in 2016. Also, there has been a spurt in incidence rate of chronic diseases worldwide. The combination of the two aforementioned factors leads to growth in demand for biopharmaceutical drugs. Though, price of these drugs are comparatively higher than generic drugs, strong demand from end users has led to rapid increase in sales of biopharmaceutical and biomedicine drugs. Development of new concept drugs along with expected commercialization of pipeline drugs is set to further spur biopharmaceuticals and biomedicine market growth. Though industry is gaining significant traction worldwide, high operational costs, stringent regulatory compliances, and supply chain complexity are major challenges for stakeholders.
Biopharmaceuticals and Biomedicine Market Introduction
Biopharmaceuticals has emerged as one of the key segments holding immense growth potential within the healthcare sector. Rising demand for effective treatment and rise in per capita healthcare expenditure has led to double digit revenue growth for industry players in recent years. The industry offers especially lucrative growth opportunities, since most of these products still have low penetration rate among the populace. The market is set to gain further traction, with evolving treatment archetypes and rapid technological innovation such as cell therapy and regenerative medicines. The global biopharmaceutical and biomedicine market was valued at over US$ 185 Mn in 2015, accounting for over 23% share of overall pharmaceuticals market and is expected to gain further market share in the near future. Major pharmaceutical companies are focusing on increasing investments in the biopharmaceuticals and biomedicine market, as the industry has yielded higher return on investment compared to generic drugs market. Thus, the biopharmaceuticals and biomedicine market is characterized by rapid rise in consolidation.
Click here to know more about this report: https://www.coherentmarketinsights.com/ongoing-insight/bio-pharmaceuticals-and-biomedicine-market-18
Inorganic growth to obtain competitive edge
Major players in the biopharmaceuticals and biomedicine market include Quest Pharmatech, Inc., AMEGA Biotech, Teva Pharmaceutical Industries, Apeiron Biologics AG, Sanofi S.A., Eli Lilly and Company, Sigma Aldrich Corporation, Mallinckrodt Pharmaceuticals, OncoMed Pharmaceuticals, Inc., and Janssen Biotech, Inc.
Companies need to constantly upgrade their manufacturing and operational capabilities in order to sustain growth in the market.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biopharmaceuticals and Biomedicine Market - Trends, Opportunity Analysis, 2016-2024 here
News-ID: 988835 • Views: …
More Releases from Biotechnology
Global Biotechnology Market Report 2019 Companies included Roche, Pfizer, Merck, …
#7th Edition Biotechnology market report recently has been published by market reports company. It features comprehensive market outlook based on historic data from 2013 to 2018 and estimated market trends during the forecast period from 2018 to 2026.
To access complete insights of global Biotechnology market report: sales@marketreportscompany.com
The Biotechnology market delivers a wide array of primary and secondary data with respect to regional and global market. In-depth analysis of numerous…
Epigenetics Market by End Users, and by Geography North America, Latin America, …
Increasing research to study the epigenetics of the genome (study called epigenomics) is expected to boost growth of the epigenetics market over the forecast period. Genome-wide epigenetic studies play an important role in the diagnostics of human diseases. Moreover, implementation of epigenetics for oncology research is estimated to propel the growth of epigenetics market. For instance, Constellation Pharmaceuticals, in April 2018, invested US$ 100 million for development of cancer epigenetics…
Industrial Microbiology–Solving Big Issues with Micro Size/Microbial Revolutio …
Advances in fields of Recombinant DNA technology, use of microorganisms in treating diseases, rising prevalence of various bacterial, and viral infections globally is expected to boost the growth of industrial microbiology market with respect to pharmaceutical industry. Use of microorganisms in manufacturing various improvised vaccines for existing as well new infectious diseases is supporting the market growth. Cosmetic industry is growing, owing to the factors, such as evolving lifestyles, increasing…
Soft Tissue Repair Market, by Product Type Fixation Products, Tissue Patch,
According to the European Union government legislature, European government will be spending almost 80 billion Euros on Research and Development to enhance a broad range of research projects. According to American Joint Replacement Registry (AJRR), around 75% increase in hospitals was reported and 41% increase in the number of surgeons from the year 2012 -2015, hence there is an increment of 102% in the number of cases related to joint…
More Releases for Biopharmaceutical
Global Biopharmaceutical Stability Testing Market
According to a new market research report published by Global Market Estimates, the Global Biopharmaceutical Stability Testing Market is projected to grow from USD 3.2 billion in 2022 to USD 10.8 billion in 2027 at a CAGR of 13.3% from 2022 to 2027.
Intertek Group plc, Eurofins Scientific, Pacific Biolabs, SGS SA, Element Materials Technology, Almac Group, Merck KGaA, Catalent, Inc., Pace Analytical Life Sciences, Boston Analytical, Kemwell Biopharma, Curia Global,…
Biopharmaceutical Testing Services Market 2021 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Biopharmaceutical Testing Services market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players’ performance based on revenue generation and client requirements. Also, the research report reveals…
BioPharmaceutical Tubing Market 2021 | Detailed Report
According to Market Study Report, BioPharmaceutical Tubing Market provides a comprehensive analysis of the BioPharmaceutical Tubing Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of BioPharmaceutical Tubing Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5024225
The report provides a comprehensive analysis of…
Biopharmaceutical Market - Massive Growth opportunity Ahead
A new research document with title 'State of the Biopharmaceutical Industry 2021' covering detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions and important players/vendors. The report will help user gain market insights, future trends and growth prospects for forecast period of 2021
Get customization & check discount for report @ https://www.htfmarketreport.com/request-discount/3060794-state-of-the-biopharmaceutical-industry
Summary
2021 promises to be a year of continued innovation and change in the…
Biopharmaceutical Logistics Market Is Thriving Worldwide |
The Biopharmaceutical Logistics Market Research Report aims to provide insights that strongly demonstrate the market structure, scope, history, potential, and development perspective. By crossing through the historical and present market status, the Biopharmaceutical Logistics market report provides authentic and reliable estimates for the forecast period.
It became essential to distinguish the saturation of consumption in the Biopharmaceutical Logistics market owing to building competitiveness. Hence, the report furnishes a deep-felt market segmentation…
The Future Of Investing: Biopharmaceutical Logistics Market
The pharmaceutical industry is dynamic and is likely to experience high growth in the coming years. Today, growing sales of drugs and biologics, changing dynamics of the pharmaceutical industry, and stringent regulatory controls are some of the factors boosting the demand for pharmaceutical logistics services.
Outsourcing logistics operations are trending in the pharma industry for cost optimization and technology advancement. Pharmaceutical companies are facing tremendous pressure for cutting down the cost of…
